Skip to content

Startups

Impel Neuropharma

Sectors
Health & Medicine

Launched
01/01/2009

Description

Impel NeuroPharma’s Pressurized Olfactory Delivery (POD) device delivers aerosolized drugs to the upper nasal cavity where they are directly transported into the brain, effectively bypassing the blood-brain barrier. The POD device enables molecules to become therapeutics that were previously unable to cross the blood-brain barrier, and often allows less drug volume to be utilized, lowering plasma exposure and reducing systemic side effects.

Team Members

Michael Hite

Co-founder and CEO

John Hoekman

Co-founder and Chief Scientific Officer

H. Stewart Parker

Member of the Board of Directors